Delivery Order SPE2DB22D2009-SPE2DB25FM1SB
- Not listed
- The Defense Logistics Agency awarded a $2,448.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). The contract is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $6,097.91. This non-competitive delivery order is expected to be completed by August 26, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,904.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This competitively awarded, non-set-aside contract is scheduled for completion by September 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens with a contract ceiling value of $22,038.06. This firm fixed-price delivery order, which will be completed by August 20, 2025, represents a competitively awarded non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,181.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pens on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $16,194.28 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,990.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price, non-competitive delivery order represents a small-value pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a $48,976.20 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1SBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 25, 2025, with a ceiling value of $96,575.56 and an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a competitive procurement with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical supply framework, the company has demonstrated its capability to fulfill federal requirements through open competition across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Mounjaro, a diabetes medication, exemplifies the contractor's role in supplying brand-name pharmaceuticals essential to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $96.6k | 9/25/25 |